Prostate cancer: Management of advanced disease

Annals of Oncology

Volumn 13, Issue SUPPL. 4, 2002, Pages 89-94

  Droz, J P ^a   Fl cechon, A ^a   Terret, C ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; AROMATASE INHIBITOR; BICALUTAMIDE; BISPHOSPHONIC ACID DERIVATIVE; BUSERELIN; CALCIUM; CORTICOSTEROID; CYPROTERONE ACETATE; DIETHYLSTILBESTROL; ESTROGEN; FIBRINOGEN; FLUTAMIDE; FOSFESTROL; GONADORELIN AGONIST; GOSERELIN; HEPARIN; LEUPRORELIN; MITOXANTRONE; NILUTAMIDE; PREDNISONE; SAMARIUM; STRONTIUM; TRIPTORELIN; VITAMIN D;

ADVANCED CANCER; ALGORITHM; ARTICLE; BONE METASTASIS; CANCER PALLIATIVE THERAPY; CASTRATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG MECHANISM; DRUG WITHDRAWAL; GYNECOMASTIA; HORMONE SENSITIVITY; HOT FLUSH; HUMAN; INFLAMMATION; LIVER TOXICITY; LUNG FIBROSIS; MALE; METASTASIS; ORCHIECTOMY; PATIENT CARE; POTENCY DISORDER; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; SIDE EFFECT; THROMBOEMBOLISM; TREATMENT PLANNING; URINE RETENTION;

EID: 0036436070     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf644     Document Type: Article

References (17)

1. Huggins C, Hodges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer J Clin 1972; 22: 232-240.
2. Bubendorf L, Schopfer A, Wagner U et al. Metastatic patterns of prostate cancer: an autopsy study of 1589 patients. Hum Pathol 2000; 31: 578-583.
3. Crawford ED, Eisenberger MA, McLeod DG et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989; 321: 419-424.
4. Eisenberger MA, Blumenstein BA, Crawford ED et al. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med 1998; 339: 1036-1042.
5. Prostate Cancer Trialists' Collaborative Group. Maximum androgen blockade in advanced prostate cancer: an overview of 22 randomised trials with 3283 deaths in 5710 patients. Lancet 1995; 346: 265-269.
6. The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. Br J Urol 1997; 79: 235-246.
7. Dawson NA. Intermittent androgen deprivation. Curr Oncol Rep 2000; 2: 409-416.
8. Scher HI, Zhang ZF, Nanus D, Kelly WK. Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer. Urology 1996; 47: 61-69.
9. Mitsiades CS, Koutsilieris M. Molecular biology and cellular physiology of refractoriness to androgen ablation therapy in advanced prostate cancer. Exp Opin Invest Drugs 2001; 10: 1099-1115.
10. Quilty PM, Kirk D, Bolger JJ et al. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol 1994; 31: 33-40.
11. Collins C, Eary JF, Donaldson G et al. Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. J Nucl Med 1993; 34: 1839-1844.
12. Farrugia D, Ansell W, Singh M et al. Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomy. Br J Urol Int 2000; 85: 1069-1073.
13. Bayley A, Milosevic M, Blend R et al. A prospective study of factors predicting clinically occult spinal cord compression in patients with metastatic prostate carcinoma. Cancer 2001; 92: 303-310.
14. Oefelein MG, Ricchuiti V, Conrad W et al. Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer. J Urol 2001; 166: 1724-1728.
15. Ransom DT, Dinapoli RP, Richardson RL. Cranial nerve lesions due to base of the skull metastases in prostate carcinoma. Cancer 1990; 65: 586-589.
16. Burgess NA, Hudd C, Rees RW. Haemostatic pitfalls in advanced prostatic cancer. Br J Urol 1993; 71: 231-233.
17. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000; 5: 224-237.